Computerized review of radiology reports found most cases requiring further imaging.
Radiology is a core part of emergency medicine practice, and inevitably, we will sometimes detect early-stage cancers while looking for other things. Researchers at a Boston emergency department (ED) assessed the frequency with which incidental findings considered by a radiologist to warrant further imaging were noted on ED discharge summaries, and they developed a computer program to identify such cases.
In an analysis of 3235 ED visits with radiology studies, further imaging was recommended in 7.9% of radiology reports, but in 51% of these cases, the discharge summaries did not mention this. In the final validation set of 1635 of the cases, the computer program was fairly sensitive overall, detecting 89% of cases that required further imag…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals